HomeInsights52 Week Low Stocks

Aarti Drugs Ltd 52 Week Low

Aarti Drugs Ltd 52 Week Low

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Jan 9, 2025)

stocks purchased

9.3 K

Stocks Traded

(Jan 9, 2025)

Last Updated on: Jan 10, 2025

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

YEARLOW

₹ 420

Last updated on: Jan 09, 2025

Key Highlights

  • The 52 Week Low of Aarti Drugs Ltd is ₹ 420 as of 09 Jan 25 .

Company Fundamentals for Aarti Drugs Ltd

No data available

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Jan 2025442.35
08 Jan 2025448.05
07 Jan 2025456.55
06 Jan 2025463
03 Jan 2025454.3
02 Jan 2025455.75
01 Jan 2025455.65
31 Dec 2024460.65
30 Dec 2024461.35
27 Dec 2024451

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Aarti Drugs Ltd News Hub

News

Aarti Drugs's receives Establishment Inspection Report for API manufacturing unit

Aarti Drugs has received Establishment Inspection Report (EIR) from USFDA concluding the i...

Read more

24 Dec 2024 15:12

News

Aarti Drugs sizzles after Tarapur facility gets EIR from USFDA

USFDA has determined that the inspection classification of this facility is voluntary acti...

Read more

24 Dec 2024 15:48

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 202...

Read more

18 Oct 2024 10:48

News

Aarti Drugs gains after arm receives UK MHRA GMP Compliance Certificate

The company said that there are no financial or material impacts as of now. With the GMP c...

Read more

04 Oct 2024 11:09

News

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

The API inspection was conducted from 12 September to 20 September 2024. At the conclusion...

Read more

21 Sep 2024 14:05

News

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

Read more

16 Sep 2024 08:52

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Aarti Drugs Ltd

Why is it important to track the 52-week low of Aarti Drugs Ltd stocks?

Investors should monitor the 52-week low of Aarti Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Aarti Drugs Ltd stocks hitting a 52-week low?

Factors leading to Aarti Drugs Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Aarti Drugs Ltd stocks when they hit a 52-week low?

Buying Aarti Drugs Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Aarti Drugs Ltd stocks?

Investors should monitor the 52-week low of Aarti Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Aarti Drugs Ltd stock at their 52-week low?

An investor can analyze the reasons for the Aarti Drugs Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Aarti Drugs Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Aarti Drugs Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Aarti Drugs Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions